ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia
B. Eichhorst, Paolo Ghia, Carsten Utoft Niemann, Arnon P. Kater, Michael Gregor, Michael Hallek, Mats Jerkeman, C. Buske
Topics & Concepts
VenetoclaxIbrutinibMedicineOncologyAlemtuzumabInternal medicineInterimRefractory (planetary science)GuidelineClinical PracticeChronic lymphocytic leukemiaLeukemiaFamily medicinePathologyTransplantationHistoryArchaeologyPhysicsAstrobiologyChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentGastrointestinal Tumor Research and Treatment